Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity - a rebuttal

被引：15
|
作者：
Sallah, S
Isaksen, M
Seremetis, S
Rojkjaer, LP
机构：
[1] Novo Nordisk AS, Biopharm, DK-2880 Bagsvaerd, Denmark
[2] Novo Nordisk AS, Int Prod Safety, DK-2820 Gentofte, Denmark
[3] Novo Nordisk AS, Med Dev, DK-2880 Bagsvaerd, Denmark
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 04期
关键词：
D O I：
10.1111/j.1538-7836.2005.01254.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：820 / 822
页数：3
相关论文
共 50 条
  • [1] Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity - reply to a rebuttal
    Aledort, LM
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 822 - 822
  • [2] Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity - a rebuttal
    Makris, M
    Van Veen, JJ
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 818 - 819
  • [3] Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VII inhibitor bypass activity
    Aledort, LM
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) : 1700 - 1708
  • [4] Thrombotic events are very rare after infusion of factor VIII inhibitor bypass activity (Feiba).
    Ehrlich, HJ
    Henzl, MJ
    Gomperts, ED
    [J]. BLOOD, 2000, 96 (11) : 82B - 82B
  • [5] Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa
    Eichinger, S.
    Lubsczyk, B.
    Kollars, M.
    Traby, L.
    Zwiauer, K.
    Gleiss, A.
    Quehenberger, P.
    Kyrle, P. A.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 707 - 713
  • [6] Treatment of an acquired factor VIII inhibitor with sequential recombinant factor VIIa and FEIBA
    Miranda, G. G.
    Rodgers, G. M.
    [J]. HAEMOPHILIA, 2009, 15 (01) : 383 - 385
  • [7] Factor VIII Inhibitor Bypass Activity and Recombinant Activated Factor VII in Cardiac Surgery
    Rao, Vidya K.
    Lobato, Robert L.
    Bartlett, Blake
    Klanjac, Mark
    Mora-Mangano, Christina T.
    Soran, P. David
    Oakes, Daryl A.
    Hill, Charles C.
    van der Starre, Pieter J.
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 28 (05) : 1221 - 1226
  • [8] CONTROL OF HEMOSTASIS WITH RECOMBINANT FACTOR-VIIA IN PATIENT WITH INHIBITOR TO FACTOR-VIII
    INGERSLEV, J
    FELDSTEDT, M
    SINDETPEDERSEN, S
    [J]. LANCET, 1991, 338 (8770): : 831 - 832
  • [9] Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor
    Montoro, JB
    Altisent, C
    Pico, M
    Cabanas, MJ
    Vila, M
    Puig, LL
    [J]. HAEMOPHILIA, 1998, 4 (05) : 762 - 765
  • [10] Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors
    Santagostino, E
    Morfini, M
    Rocino, A
    Baudo, F
    Scaraggi, FA
    Gringeri, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (04) : 954 - 958
12345